We have two unfilled positions still available for Early Stage Researchers to work on the INSPiRE-MED European project.
We seek highly motivated and qualified individuals to fill the last two Early Stage Researcher three-years positions still available in the project. The successful candidates will contribute to the development of advanced biomedical research tools in the field of Magnetic Resonance Spectroscopy and Imaging, and its application to the clinical day-to-day practice.
The positions still available are:
ESR9: Glutamate neurotransmission in depression: combining receptor and metabolic information from simultaneous MR/PET. At The University of Manchester, United Kingdom. Job description – Apply
ESR12: A decision-support system based on MRSI data at 3T, for glioblastoma therapy response follow- up. At Consorcio Centro de Investigacion Biomédica en Red M.P. (CIBER), Barcelona, Spain. Job description – Apply
To apply to one or more of the available positions, follow the instructions at the bottom of their description document at the INSPiRE-MED website or click the “Where to apply” button in the description pages at the EURAXESS jobs portal.
Before applying, note that Early Stage Researchers are subject to the Eligibility and Mobility Rules:
Early-Stage Researchers shall, at the time of recruitment by the host organisation, be in the first four years (full-time equivalent research experience) of their research careers and have not been awarded a doctoral degree.
At the time of recruitment by the host organisation, researchers must not have resided or carried out their main activity (work, studies, etc.) in the country of their host organisation for more than 12 months in the 3 years immediately prior to the reference date.
We are recruiting 15 Early Stage Researchers to work on the INSPiRE-MED European project.
We seek highly motivated and qualified individuals to fill the 15 Early Stage Researcher three-years positions available in the project. The successful candidates will contribute to the development of advanced biomedical research tools in the field of Magnetic Resonance Spectroscopy and Imaging, and its application to the clinical day-to-day practice.
Before applying, note that Early Stage Researchers are subject to the Eligibility and Mobility Rules:
Early-Stage Researchers shall, at the time of recruitment by the host organisation, be in the first four years (full-time equivalent research experience) of their research careers and have not been awarded a doctoral degree.
At the time of recruitment by the host organisation, researchers must not have resided or carried out their main activity (work, studies, etc.) in the country of their host organisation for more than 12 months in the 3 years immediately prior to the reference date.
The available positions are:
ESR 1: Optimized sets of MRS scans for fingerprinting and dedicated parameter estimation by fitting or deep learning. At Universität Bern, Switzerland.
ESR 2: Maximize metabolic information in a multi-parametric study at ultra-high field, from pre-clinical to clinical validations. At École Polythechnique Fédérale de Lausanne, Switzerland.
ESR 3: Next generation of multinuclear MRS(I). At MR Code B.V., Utrecht, The Netherlands.
ESR 4: Implementation of high-resolution MRSI methods in a pre-clinical scanner, and optimization for brain longitudinal studies of therapy response in mice glioma models. At Universitat Autònoma de Barcelona, Spain.
ESR 5: Efficient quantum-mechanics based simulation of metabolite excitation for fingerprinting and iterative parameter estimation. At Ustav pristrojove techniky AVCR, v. v. i. (Institute of Scientific Instruments of the Czech Academy of Sciences), Brno, Czech Republic.
ESR 6: Quantification and cross-validation of metabolic biomarkers in preclinical disease models. At Katholieke Universiteit Leuven, Belgium.
ESR 7: Development of automatic pipelines for MRS(I)/PET data processing and machine learning methods for prognostic and classification in Multiple Sclerosis patients. At Université Claude Bernard-Lyon1, Lyon, France) –
ESR 8: Pathophysiology of Tourette syndrome: multimodal characterization of metabolic alterations. At Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Ev (Max Planck Institute for Human Cognitive and Brain Sciences), Leipzig, Germany.
ESR9: Glutamate neurotransmission in depression: combining receptor and metabolic information from simultaneous MR/PET. At The University of Manchester, United Kingdom.
ESR10: Integrated acquisition & post-processing of MR spectroscopic imaging (MRSI) data of the prostate. At Radboud University Medical Center, Nijmegen, The Netherlands.
ESR11: Automated nosologic imaging by fusing multiparametric MR information in longitudinal patient follow-up. At Katholieke Universiteit Leuven, Belgium.
ESR12: A decision-support system based on MRSI data at 3T, for glioblastoma therapy response follow- up. At Consorcio Centro de Investigacion Biomédica en Red M.P. (CIBER), Barcelona, Spain.
ESR13: Boosting the academic jMRUI with novel algorithms and data format standardization. At Ustav pristrojove techniky AVCR, v. v. i. (Institute of Scientific Instruments of the Czech Academy of Sciences), Brno, Czech Republic.
ESR14: Validation and CE documentation of a Magnetic Resonance Spectroscopy clinical pipeline as a medical device. At ICOMETRIX N.V., Leuven, Belgium.
ESR15: Development of robust, user-friendly analysis and reporting tools for automatic MRS(I) processing for use in a clinical setting. At Universitätsspital Bern, Switzerland.
To apply to one or more of the available positions, follow the instructions at the bottom of their description document at the INSPiRE-MED website or click the “Where to apply” button in the description pages at the EURAXESS jobs portal.
Integrating Magnetic Resonance Spectroscopy and Multimodal Imaging for Research and Education in MEDicine (INSPiRE-MED) is an European research project awarded in the call H2020-MSCA-ITN-2018, of the MSCA-ITN-ETN – European Training Networks, to a consortium of 12 academic partners and 9 industrial partners coordinated by Prof. Dominique Sappey-Marinier, of the Université Lyon-1 Claude-Bernard, Lyon, France.
Starting 1st of January 2019, the INSPIRE-MED Initial Training Network will investigate over the next four years the theoretical and practical aspects of in vivo Magnetic Resonance Spectroscopy (MRS) and Spectroscopic Imaging (MRSI) with applications in oncology and neurology.
MRS(I) is a unique non-invasive technique that provides insight on in-vivo metabolite content, an information that is highly relevant for the diagnosis and therapy follow-up in numerous disease models and patients. Despite such potential, clinical uptake of MRS(I) is lagging behind that of MRI and PET, mainly because of limited availability of efficient, robust and automatic software tools. Thus, INSPiRE-MED aims at establishing MRS(I) as an additional tool integrated into clinical routine imaging, but also extending its benefits with next-generation research methods. For this purpose, INSPiRE-MED will create novel MRS(I) methodology, integrate MRS(I) into multimodal MR/PET clinical metabolic imaging protocols, develop latest machine learning methods for data analysis and provide a clinical version of jMRUI, a worldwide unique data processing tool for MRS(I).
If you are a user of either the jMRUI software, the INTERPRET Decision Support System or the SpectraClassifier tool, we would like to know how you use these software tools and your opinion about them, so that we can keep improving our software to better serve your needs.
For that purpose, we ask you to participate in the TRANSACT-ITN final software survey by answering few questions about your training, your working environment, the data you process, and how you use and rate the software. Although most questions are mandatory, many are so trivial that you will answer them in a blink, and the full questionnaire should take you less than 15 minutes to complete, and less than 10 minutes if you only use the jMRUI software. The questionnaire has been tested with the most popular web browsers running on desktop computers and mobile phones and tablets, and you should be able to answer it from elsewhere.
The survey is brought to you by TRANSACT, the EU-funded FP7-PEOPLE Marie Curie Initial Training Network (ITN) project that has been fostering the development of the jMRUI software from March 1, 2013 to February 28, 2017. The aim of the project was to Transform Magnetic Resonance Spectroscopy into a Clinical Tool, and two of the main objectives of the project were:
to improve the usability of the jMRUI software in the clinics, and
Cookies are small text files held on your computer. We use them to improve your browsing experience of our site. By visiting our website you accept our use of cookies. For more information about cookies and how we use them, please visit our Our website uses cookies page.